ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

53
Analysis
Health CareTaiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
07 Oct 2024 07:05

TWSE Foreign Holding Weekly (Oct 4th): Via Technologies, TSMC, United Microelectronics

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Via Technologies, TSMC, United Microelectronics,...

Logo
199 Views
Share
23 Sep 2024 14:31

Quiddity TDIV/50/​​​100 Sep 24 Rebal: 100% Hit Rate; Perfectly Positioned for Our Trade

The TDIV index change flows and capping flows will be equally distributed over five trading days (close of trading on 20th, 23rd, 24th, 25th, and...

Share
23 Sep 2024 07:05

TWSE Foreign Holding Weekly (Sep 20th): TSMC, Shin Kong Financial, Evergreen Marine Corp Taiwan

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Shin Kong Financial, Evergreen Marine Corp...

Logo
235 Views
Share
16 Sep 2024 07:05

TWSE Foreign Holding Weekly (Sep 13th): Quanta Computer, TSMC, Ctbc Financial

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Quanta Computer, TSMC, Ctbc Financial, Hon Hai...

Logo
254 Views
Share
11 Sep 2024 02:36

Taiwan Tech Weekly: TSMC Becoming More Dominant; Apple's AI Opportunity; Taiwan Market Hammered

​TSMC extending its lead in global foundry with Intel and Samsung needing help. Apple best positioned deliver the AI phone 'dream'. Taiwan market...

Logo
408 Views
Share
x